Advanced Therapy Medicinal Product

Advanced Therapy Medicinal Products, or ATMPs, are advanced therapeutic drugs that are based on cell therapy or gene therapy (sometimes in combination with a medical device. The criteria to which a drug must conform to be classified as an ATMP, are defined in Article 17 of Regulation (EC) No 1394/2007 by the European Commission.[1]

References

  1. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-20. Retrieved 2020-11-01.{{cite web}}: CS1 maint: archived copy as title (link)


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.